Molecular interactions in the formation and deposition of β2-microglobulin-related amyloid fibrils

In β2-microglobulin-related (Aβ2M) amyloidosis, a serious complication in patients on long-term dialysis, partial unfolding of β2-microglobulin (β2-m) is believed to be prerequisite to its assembly into Aβ2M amyloid fibrils. Many kinds of amyloid-associated molecules, (e.g., apolipoprotein E (apoE), glycosaminoglycans (GAGs), proteoglycans (PGs)) may contribute to the development of Aβ2M amyloidosis. In 1990s, the formation of Aβ2M amyloid fibrils in vitro was first observed at low pH (2.0–3.0). Very recently, low concentrations of 2,2,2-trifluoroethanol (TFE) and the sub-micellar concentration of sodium dodecyl sulfate, a model for anionic phospholipids, have been reported to cause the extension of Aβ2M amyloid fibrils at a neutral pH, inducing partial unfolding of β2-m and stabilization of the fibrils. Moreover, apoE, GAGs, and PGs were found to stabilize Aβ2M amyloid fibrils at a neutral pH, forming a stable complex with the fibrils. Some GAGs, especially heparin, enhanced the fibril extension in the presence of TFE at a neutral pH. Some PGs, especially biglycan also induced the polymerization of acid-denatured β2-m. These findings are consistent with the hypothesis that in vivo, specific molecules that affect the conformation and stability of β2-m and amyloid fibrils will have significant effects on the deposition of Aβ2M amyloid fibrils.

[1]  Suguru Yamamoto,et al.  Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Biochemistry.

[2]  山本 卓 Glycosaminoglycans enhance the trifluoroethanol-induced extension of β2-Microglobulin-related amyloid fibrils at a neutral pH , 2004 .

[3]  F. Gejyo,et al.  Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  K. Ohashi,et al.  Proteoglycans in haemodialysis-related amyloidosis , 2004, Virchows Archiv.

[5]  F. Gejyo,et al.  Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. , 2003, Kidney international.

[6]  J. Torres,et al.  Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I* , 2003, The Journal of Biological Chemistry.

[7]  J. Ancsin Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[8]  C. Dobson,et al.  Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS , 2002, FEBS letters.

[9]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[10]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Hoshino,et al.  Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange , 2002, Nature Structural Biology.

[12]  S. Ji,et al.  Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.

[13]  K. Ohashi,et al.  Affinity Binding of Glycosaminoglycans with β2-Microglobulin , 2002, Nephron.

[14]  M. Hoshino,et al.  Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids. , 2002, Biochemistry.

[15]  W. Szarek,et al.  Novel glycosaminoglycan precursors as anti-amyloid agents part II , 2002, Journal of Molecular Neuroscience.

[16]  C. Dobson,et al.  A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.

[17]  D A Smith,et al.  Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.

[18]  N. Heegaard,et al.  Conformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH* , 2001, The Journal of Biological Chemistry.

[19]  F. Gejyo,et al.  Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2001, Biochemistry.

[20]  Y. Kozutsumi,et al.  Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid* , 2001, The Journal of Biological Chemistry.

[21]  C. Dobson,et al.  Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. , 2001, Journal of molecular biology.

[22]  P. Fraser,et al.  Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development. , 2001, The Journal of biological chemistry.

[23]  D. Heinegård,et al.  Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. , 2001, Osteoarthritis and cartilage.

[24]  T. Chiba,et al.  Transmission of Mouse Senile Amyloidosis , 2001, Laboratory Investigation.

[25]  P. Fraser,et al.  Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. , 2000, European journal of biochemistry.

[26]  A. Koide,et al.  Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. , 2000, Journal of molecular biology.

[27]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Dobson,et al.  Evidence concerning rate-limiting steps in protein folding from the effects of trifluoroethanol , 2000, Nature Structural Biology.

[29]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[30]  S. Paul,et al.  Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Fraser,et al.  Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.

[32]  P. Roughley,et al.  Age-related changes in fibromodulin and lumican in human intervertebral discs. , 1999, Spine.

[33]  M. Jadoul,et al.  Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. , 1999, Kidney international.

[34]  R. Kisilevsky,et al.  The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A , 1999, The Journal of Biological Chemistry.

[35]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[36]  F. Gejyo,et al.  Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. , 1998, Biochemistry.

[37]  M. Okita,et al.  The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. , 1998, Journal of nutritional science and vitaminology.

[38]  M. Jadoul,et al.  Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. , 1998, Kidney international.

[39]  M. Buck,et al.  Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins , 1998, Quarterly Reviews of Biophysics.

[40]  R. Iozzo Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[41]  D. Rader,et al.  Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. , 1998, The American journal of pathology.

[42]  M. Judge,et al.  Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. , 1998, Diabetes.

[43]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[44]  K. Ohashi,et al.  Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. , 1997, Kidney international.

[45]  S. K. Lim,et al.  Serum amyloid P component enhances induction of murine amyloidosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[46]  D. Cui,et al.  Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice. , 1997, American Journal of Pathology.

[47]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[48]  À. Argilés,et al.  Monomeric and dimeric beta 2-microglobulin may be extracted from amyloid deposits in vitro. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  K. Ohashi,et al.  Visceral organ involvement and extracellular matrix changes in β2-microglobulin amyloidosis – a comparative study with systemic AA and AL amyloidosis , 1997, Virchows Archiv.

[50]  F. Gejyo,et al.  Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. , 1997, Biochemistry.

[51]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[52]  Satoru Suzuki,et al.  Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .

[53]  Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 allele , 1997 .

[54]  M. Skinner,et al.  Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. , 1996, Kidney international.

[55]  F. Gejyo,et al.  High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. , 1996, Arthritis and rheumatism.

[56]  R. Wetzel,et al.  Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. , 1996, Biochemistry.

[57]  R. Strugnell,et al.  Eukaryotic Expression of Recombinant Biglycan , 1996, The Journal of Biological Chemistry.

[58]  M. Pepys,et al.  Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. , 1996, Kidney international.

[59]  Thomas Wisniewski,et al.  The Interaction between Apolipoprotein E and Alzheimers Amyloid -Peptide Is Dependent on -Peptide Conformation (*) , 1996, The Journal of Biological Chemistry.

[60]  T. Wisniewski,et al.  THE INTERACTION BETWEEN APOLIPOPROTEIN E AND ALZHEIMERʼS AMYLOID β-PEPTIDE IS DEPENDENT ON β-PEPTIDE CONFORMATION , 1996 .

[61]  H. Naiki,et al.  First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[62]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[63]  M. Kindy,et al.  Association of apolipoprotein E with murine amyloid A protein amyloid. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[64]  Y. Ihara,et al.  GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease , 1995, Nature Medicine.

[65]  J. Laredo,et al.  Dialysis arthropathy: outcome after renal transplantation. , 1995, The American journal of medicine.

[66]  K. Brunden,et al.  Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. , 1995, The Journal of biological chemistry.

[67]  M. Pras,et al.  Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L , 1995, The Journal of Biological Chemistry.

[68]  L. Lovat,et al.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[69]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[70]  H Kresse,et al.  Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.

[71]  P. Fraser,et al.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.

[72]  P. Lansbury,et al.  Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[73]  K. Nishikawa,et al.  Trifluoroethanol-induced Stabilization of the α-Helical Structure of β-Lactoglobulin: Implication for Non-hierarchical Protein Folding , 1995 .

[74]  A. Davison beta 2-microglobulin and amyloidosis: who is at risk? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[75]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[76]  T Vogel,et al.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.

[77]  G Pogány,et al.  The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. , 1994, Archives of biochemistry and biophysics.

[78]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[79]  F. Gejyo,et al.  A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits. , 1994, Annals of clinical and laboratory science.

[80]  T. Wisniewski,et al.  Alzheimer's disease and soluble Aβ , 1994, Neurobiology of Aging.

[81]  P. Roughley,et al.  Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[82]  P. Roughley,et al.  Non-proteoglycan forms of biglycan increase with age in human articular cartilage. , 1993, The Biochemical journal.

[83]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[84]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Volanakis,et al.  The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.

[86]  M. Skinner,et al.  Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits. , 1992, Kidney international.

[87]  M. Solé,et al.  In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. , 1992, The American journal of pathology.

[88]  K. Ohashi,et al.  Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. , 1992, Kidney international.

[89]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[90]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  F. Oppenheimer,et al.  Renal transplantation for dialysis amyloidosis. , 1992, Transplantation proceedings.

[92]  R. Bramson,et al.  A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[93]  M. Pepys,et al.  Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component , 1991, The Lancet.

[94]  K. Higuchi,et al.  Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[95]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[96]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[97]  F. Gejyo,et al.  Dialysis amyloidosis: current disease concepts and new perspectives for its treatment. , 1990, Contributions to nephrology.

[98]  M. Skinner,et al.  Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. , 1990, Clinical chemistry.

[99]  B. Maldague,et al.  Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. , 1989, Clinical nephrology.

[100]  O. Toupance,et al.  Carpal tunnel syndrome and type of dialysis membrane. , 1989, BMJ.

[101]  C. Kay,et al.  Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.

[102]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[103]  T. Bardin,et al.  Dialysis related amyloidosis. , 1987, The Journal of rheumatology.

[104]  N. Tuross,et al.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. , 1987, The Journal of biological chemistry.

[105]  B. Frangione,et al.  Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[106]  F. Gejyo,et al.  Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. , 1986, The New England journal of medicine.

[107]  M Arakawa,et al.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.

[108]  L. Tang,et al.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.

[109]  B. Charra,et al.  Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

[110]  B Honig,et al.  Crystallographic studies of protein denaturation and renaturation. 2. Sodium dodecyl sulfate induced structural changes in triclinic lysozyme. , 1977, Biochemistry.

[111]  W. Mattice,et al.  Conformational properties of the complexes formed by proteins and sodium dodecyl sulfate. , 1976, Biochemistry.

[112]  C. Tanford,et al.  The gross conformation of protein-sodium dodecyl sulfate complexes. , 1970, The Journal of biological chemistry.

[113]  B. Jirgensons Effects of n-propyl alcohol and detergents on the optical rotatory dispersion of alpha-chymotrypsinogen, beta-casein, histone fraction F1, and soybean trypsin inhibitor. , 1967, The Journal of biological chemistry.